Rheumatoid arthritis Market Research Report- Forecast To 2027

Rheumatoid arthritis market Size, Trends and Growth Outlook by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2027

ID: MRFR/Pharma/1127-HCR | February 2021 | Region: Global | 85 pages

Rheumatoid Arthritis Market Scenario:


The rheumatoid arthritis market is expected to grow at the rate of about XX% CAGR from 2020 to 2027. Globally the market for rheumatoid arthritis is increasing rapidly. The major factor that derives the growth of rheumatoid arthritis is the increasing aging population. Furthermore, some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis.


Key Players for Rheumatoid Arthritis Market:


Some of the key players in this market are: Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) and many others.


Rheumatoid Arthritis Market Segments:


rheumatoid arthritis market has been segmented on the basis of drug type which comprises of Non-steroidal anti-inflammatory drug type (NSAID), Steroids, and Disease-modifying anti-rheumatic drug type (DMARDs) and Biologic agents. On the basis of treatment include Synovectomy, Tendon repair, Joint fusion and Total joint replacement. Furthermore, on the basis of diagnosis includes C - reactive protein (CRP) Test, CCP, ESR (Erythrocyte Sedimentation Rate) Test and Synovial Fluid Analysis. 


Regional Analysis of Rheumatoid arthritis Market:                                               


Globally North America is the largest market for rheumatoid arthritis. The North American market for rheumatoid arthritis is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Europe is the second-largest market for rheumatoid arthritis which is expected to grow at a CAGR of XX%. Furthermore, Asia pacific market is expected to be the fastest growing market for rheumatoid arthritis.


 The report for Global Rheumatoid Arthritis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.


Study Objectives of Rheumatoid arthritis Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the rheumatoid arthritis market  

  • To provide insights about factors affecting the market growth

  • To analyze the rheumatoid arthritis market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by drug type, by diagnosis, by treatment and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global


Intended Audience



  • Pharmaceutical companies

  • Rheumatoid arthritis treatment centers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   drug type, diagnosis and treatment
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer Inc (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (switzerland), Novartis AG (switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K)
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments
  Key Market Drivers   Increasing aging population


Frequently Asked Questions (FAQ) :


global rheumatoid arthritis market is estimated to grow at approximately 4% CAGR during the review period (2017-2022).

Huge investments for the development of products related to rheumatoid arthritis treatment and rise in the global economy that is widening the access to the quality care are the major tailwinds pushing the growth of the global rheumatoid arthritis market.

North America holds the largest share in the global rheumatoid arthritis market, followed by Europe and the Asia Pacific, respectively.

Eli Lilly and company (US), Pfizer Inc. (US), Bristol-Myers Squibb Company (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Vertex Pharmaceuticals Incorporated (US), AstraZeneca (UK), and Sanofi (France), are some of the major players operating in the rheumatoid arthritis market.

Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global rheumatoid arthritis market adopt to gain a larger competitive advantage.